{"id":8049,"date":"2022-02-18T11:31:00","date_gmt":"2024-02-02T20:26:49","guid":{"rendered":"https:\/\/chilluh.nl\/index.php\/2024\/02\/02\/esmo-2024-abstracts-date\/"},"modified":"2022-02-18T11:31:00","modified_gmt":"2024-02-02T20:26:49","slug":"esmo-2024-abstracts-date","status":"publish","type":"post","link":"https:\/\/werelivingwell.com\/rudqg-esmo-2024-abstracts-date-mcdzn-pictures\/","title":{"rendered":"Esmo 2024 Abstracts Date"},"content":{"rendered":"<div class=\"cd5c096581fd5fc23b44a4969c1e3c2e\" data-index=\"1\" style=\"float: none; margin:10px 0 10px 0; text-align:center;\">\n<div style='text-align: center;'>\r\n<script type=\"text\/javascript\">\r\n\tatOptions = {\r\n\t\t'key' : '0a1f35073c594f712b44ac459670782f',\r\n\t\t'format' : 'iframe',\r\n\t\t'height' : 250,\r\n\t\t'width' : 300,\r\n\t\t'params' : {}\r\n\t};\r\n\tdocument.write('<scr' + 'ipt type=\"text\/javascript\" src=\"\/\/www.profitablecreativeformat.com\/0a1f35073c594f712b44ac459670782f\/invoke.js\"><\/scr' + 'ipt>');\r\n<\/script>\r\n<\/div>\r\n\n<\/div>\n<p>\t\t\t\t<![CDATA[\n\n<p><b>Esmo 2024 Abstracts Date<\/b> &#8211; Iovance&#8217;s lifileucel, a promising tumor infiltrating lymphocyte cell therapy for melanoma, awaits FDA approval with potential for significant  . J&amp;J\u2019s Balversa gets US FDA full approval to treat locally advanced or metastatic bladder cancer with select genetic alterations: Raritan, New Jersey Monday, January 22, 2024, 11  .<\/p>\n\n\n\n\n<h2>Esmo 2024 Abstracts Date<\/h2>\n\n\n\n\n<p align=\"center\"> <a title=\"Abstracts | ESMO Breast Cancer 2024\"><img decoding=\"async\" src=\"https:\/\/www.esmo.org\/var\/esmo\/storage\/images\/media\/esmo\/meetings\/2024\/esmo-breast-cancer-2024\/images\/esmo-breast-cancer-2024-1000x250\/17803094-1-eng-GB\/esmo-breast-cancer-2024-1000x250_i1200.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n\n\nSource : <a href=\"https:\/\/www.esmo.org\">www.esmo.org<\/a>\n\n\n<h2>ESMO   Eur. Oncology on X: &#8220;#ESMOTAT24: Be part of this <\/h2>\n\n\n\n\n<p align=\"center\"><a><img decoding=\"async\" src=\"https:\/\/pbs.twimg.com\/media\/F7R1t73XoAAQKcx.jpg:large\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n\n\nSource : <a href=\"https:\/\/twitter.com\" rel=\"nofollow\">twitter.com<\/a>\n\n\n<h2>Abstracts | ESMO Congress 2024<\/h2>\n\n\n\n\n<p align=\"center\"><a title=\"Abstracts | ESMO Congress 2024\"><img decoding=\"async\" src=\"https:\/\/www.esmo.org\/var\/esmo\/storage\/images\/media\/esmo\/meetings\/2024\/esmo-congress-2024\/images\/esmo-congress-2024-1000x250\/14654927-2-eng-GB\/esmo-congress-2024-1000x250_i1200.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n\n\nSource : <a href=\"https:\/\/www.esmo.org\" rel=\"nofollow\">www.esmo.org<\/a>\n\n\n<h2>Lillian Siu (@lillian_siu) \/ X<\/h2>\n\n\n\n\n<p align=\"center\"> <a title=\"Lillian Siu (@lillian_siu) \/ X\"><img decoding=\"async\" src=\"https:\/\/pbs.twimg.com\/media\/GAokF4eWwAAcmJd.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n\n\nSource : <a href=\"https:\/\/twitter.com\" rel=\"nofollow\">twitter.com<\/a>\n\n\n<h2>Abstracts | ESMO Gastrointestinal Cancers Congress 2024<\/h2>\n\n\n\n\n<p align=\"center\"> <a title=\"Abstracts | ESMO Gastrointestinal Cancers Congress 2024\"><img decoding=\"async\" src=\"https:\/\/www.esmo.org\/var\/esmo\/storage\/images\/media\/esmo\/meetings\/2024\/esmo-gastrointestinal-cancers-2024\/esmo-gastrointestinal-cancers-2024-1000x250\/17877610-1-eng-GB\/esmo-gastrointestinal-cancers-2024-1000x250_i1200.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n\n\nSource : <a href=\"https:\/\/www.esmo.org\" rel=\"nofollow\">www.esmo.org<\/a>\n\n\n<h2>ESMO   Eur. Oncology on X: &#8220;#ESMOTAT24: Be part of this <\/h2>\n\n\n\n\n<p align=\"center\"> <a><img decoding=\"async\" src=\"https:\/\/pbs.twimg.com\/media\/F7R1t73XoAAQKcx.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n\n\nSource : <a href=\"https:\/\/twitter.com\" rel=\"nofollow\">twitter.com<\/a>\n\n\n<h2>Abstracts | ESMO Sarcoma and Rare Cancers Congress 2024<\/h2>\n\n\n\n\n<p align=\"center\"> <a title=\"Abstracts | ESMO Sarcoma and Rare Cancers Congress 2024\"><img decoding=\"async\" src=\"https:\/\/www.esmo.org\/var\/esmo\/storage\/images\/media\/esmo\/meetings\/2024\/esmo-sarcoma-and-rare-cancers-2024\/images\/esmo-sarcoma-and-rare-cancers-congress-2024-1000x250\/17394824-3-eng-GB\/esmo-sarcoma-and-rare-cancers-congress-2024-1000x250_i1200.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n\n\nSource : <a href=\"https:\/\/www.esmo.org\" rel=\"nofollow\">www.esmo.org<\/a>\n\n\n<h2>ESMO   European Society for Medical Oncology on LinkedIn: #esmotat24<\/h2>\n\n\n\n\n<p align=\"center\"> <a title=\"ESMO   European Society for Medical Oncology on LinkedIn: #esmotat24\"><img decoding=\"async\" src=\"https:\/\/media.licdn.com\/dms\/image\/D4E10AQFIhOGqFs1sgA\/image-shrink_800\/0\/1696147225001?e=2147483647&amp;v=beta&amp;t=soc7iJMBuALMyD--BW5eLzAjZMutWn15atdUe6FDMFg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n\n\nSource : <a href=\"https:\/\/www.linkedin.com\" rel=\"nofollow\">www.linkedin.com<\/a>\n\n\n<h2>Abstracts | ESMO Gynaecological Cancers Congress 2024<\/h2>\n\n\n\n\n<p align=\"center\"> <a title=\"Abstracts | ESMO Gynaecological Cancers Congress 2024\"><img decoding=\"async\" src=\"https:\/\/www.esmo.org\/var\/esmo\/storage\/images\/media\/esmo\/meetings\/2024\/esmo-gynaecological-cancers-2024\/images\/esmo-gynaecological-cancers-congress-2024-1000x250\/17203126-2-eng-GB\/esmo-gynaecological-cancers-congress-2024-1000x250_i1920.jpg\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n\n\nSource : <a href=\"https:\/\/www.esmo.org\" rel=\"nofollow\">www.esmo.org<\/a>\n\n\n<h2>Learn about lung cancer at ELCC24 | ESMO   European Society for <\/h2>\n\n\n\n\n<p align=\"center\"> <a title=\"Learn about lung cancer at ELCC24 | ESMO   European Society for \"><img decoding=\"async\" src=\"https:\/\/media.licdn.com\/dms\/image\/D4E10AQHq7bjIr4qRsA\/image-shrink_800\/0\/1695751250446?e=2147483647&amp;v=beta&amp;t=W0JS-OtbxT_cVdP3q5L-9BM-ri0y6OVtvsCqzshaQAo\" width=\"100%\" height=\"100%\"><\/a> <\/p>\n\n\nSource : <a href=\"https:\/\/www.linkedin.com\" rel=\"nofollow\">www.linkedin.com<\/a>\n\n\n<p><b>Esmo 2024 Abstracts Date Abstracts | ESMO Breast Cancer 2024<\/b>:   Iovance&#8217;s lifileucel, a promising tumor infiltrating lymphocyte cell therapy for melanoma, awaits FDA approval with potential for significant  . J&amp;J\u2019s Balversa gets US FDA full approval to treat locally advanced or metastatic bladder cancer with select genetic alterations: Raritan, New Jersey Monday, January 22, 2024, 11  . <\/p>\n\n\n]]>\t\t<\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>\t\t\t\t<![CDATA[]]>\t\t<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/werelivingwell.com\/wp-json\/wp\/v2\/posts\/8049"}],"collection":[{"href":"https:\/\/werelivingwell.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/werelivingwell.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/werelivingwell.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/werelivingwell.com\/wp-json\/wp\/v2\/comments?post=8049"}],"version-history":[{"count":0,"href":"https:\/\/werelivingwell.com\/wp-json\/wp\/v2\/posts\/8049\/revisions"}],"wp:attachment":[{"href":"https:\/\/werelivingwell.com\/wp-json\/wp\/v2\/media?parent=8049"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/werelivingwell.com\/wp-json\/wp\/v2\/categories?post=8049"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/werelivingwell.com\/wp-json\/wp\/v2\/tags?post=8049"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}